Obbligazioni
Di seguito è riportato l'elenco delle obbligazioni societarie Bristol-Myers Squibb Company. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
---|---|---|---|---|---|---|---|---|---|
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,95% | 30 K | 82,51% | 5,250% | 2043-08-15 | 4,06 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,58% | 100 K | 79,04% | 4,625% | 2044-05-15 | 3,69 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6,08% | 8 K | 87,60% | 5,000% | 2045-08-15 | 15,71 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,97% | 5 K | 80,09% | 4,350% | 2047-11-15 | 13,57 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
5,78% | 30 K | 118,50% | 6,875% | 2097-08-01 | 62,42 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,78% | 20 K | 84,30% | 4,550% | 2048-02-20 | 37,2 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
5,63% | 0 | 112,06% | 6,400% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,60% | 21 K | 100,91% | 5,700% | 2040-10-15 | 2,3 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
5,57% | 0 | 101,13% | 5,650% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,56% | 0 | 74,11% | 3,900% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,49% | 0 | 110,78% | 6,250% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,46% | 0 | 101,23% | 5,550% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,44% | 0 | 75,75% | 3,700% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,44% | 587 K | 88,54% | 4,550% | 2048-02-20 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,42% | 735 K | 84,39% | 4,250% | 2049-10-26 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,41% | 342 K | 86,43% | 4,350% | 2047-11-15 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,40% | 0 | 61,05% | 2,550% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,39% | 0 | 89,69% | 4,500% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,34% | 30 K | 98,93% | 5,250% | 2043-08-15 | 218,37 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,31% | 0 | 102,13% | 5,500% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,26% | 296 K | 96,72% | 5,000% | 2045-08-15 | 741,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,26% | 20,05 M | 92,54% | 4,625% | 2044-05-15 | 744,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,23% | 100 K | 108,12% | 6,125% | 2038-05-01 | 219,25 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,22% | 0 | 81,73% | 3,550% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 14 K | 78,23% | 3,250% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,15% | 9 K | 105,67% | 5,700% | 2040-10-15 | 151,01 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,07% | 0 | 71,51% | 2,350% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,93% | 8,95 M | 92,00% | 4,125% | 2039-06-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,81% | 1,42 M | 109,04% | 5,875% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,53% | 0 | 104,58% | 5,200% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,51% | 0 | 100,13% | 4,950% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,49% | 0 | 109,46% | 5,900% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,36% | 108 K | 99,73% | 0,750% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,28% | 50 K | 99,14% | 3,900% | 2028-02-20 | 43,84 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
4,28% | 0 | 92,62% | 2,950% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,14% | 0 | 104,56% | 5,100% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,13% | 0 | 107,63% | 5,750% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 4,02% | 150 K | 98,89% | 3,450% | 2027-11-15 | 16,55 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
4,01% | 4,58 M | 88,36% | 1,450% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,96% | 0 | 99,06% | 3,250% | 2027-02-27 | 512,28 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,92% | 1,44 M | 98,18% | 3,400% | 2029-07-26 | 2,37 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,91% | 0 | 103,07% | 4,900% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,87% | 0 | 101,33% | 4,900% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,82% | 500 K | 98,50% | 3,400% | 2029-07-26 | 26,56 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,79% | 13,95 M | 99,62% | 3,200% | 2026-06-15 | 1,74 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,73% | 6,02 M | 100,35% | 3,900% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,71% | 539 K | 99,49% | 3,450% | 2027-11-15 | 517,67 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,68% | 0 | 94,95% | 1,125% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,62% | 362 K | 103,34% | 6,800% | 2026-11-15 | 255,95 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
3,35% | 0 | 87,03% | 1,750% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
2,74% | 0 | 130,24% | 4,250% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,70% | 0 | 141,76% | 5,000% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,62% | 0 | 137,60% | 4,550% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,60% | 0 | 122,76% | 4,125% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,31% | 0 | 104,25% | 3,200% | 2026-06-15 | 5,95 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,57% | 0 | 116,80% | 3,900% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,36% | 0 | 114,77% | 3,450% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
— | 30 K | 100,10% | 4,784% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |